1. Home
  2. MRKR vs YAAS Comparison

MRKR vs YAAS Comparison

Compare MRKR & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

BUY

Current Price

$0.95

Market Cap

19.5M

Sector

Health Care

ML Signal

BUY

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

N/A

Current Price

$1.02

Market Cap

20.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MRKR
YAAS
Founded
1999
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
20.9M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
MRKR
YAAS
Price
$0.95
$1.02
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $7.87
N/A
AVG Volume (30 Days)
★ 60.0K
16.0K
Earning Date
11-12-2026
08-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.61
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$19.61
N/A
Revenue Next Year
$375.85
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.84
$0.56
52 Week High
$2.46
$4.98

Technical Indicators

Market Signals
Indicator
MRKR
YAAS
Relative Strength Index (RSI) 31.50 30.10
Support Level N/A $0.87
Resistance Level $1.31 $1.41
Average True Range (ATR) 0.07 0.08
MACD -0.02 0.01
Stochastic Oscillator 5.58 3.03

Price Performance

Historical Comparison
MRKR
YAAS

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: